SBC Medical Group Holdings Incorporated Warrants financials
$0.4000+14.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $173.6M | $205.4M |
| Gross profit | $127.3M | $156.1M |
| Gross margin | 73.3% | 76.0% |
| Operating income | $67.5M | $70.3M |
| Net income | $51.0M | $46.6M |
| Net margin | 29.4% | 22.7% |
| Diluted EPS | $0.50 | $0.48 |
| EBITDA | $70.2M | $89.2M |
| Operating cash flow | $24.7M | $20.6M |
| Free cash flow | $22.3M | $17.2M |
| Diluted shares | 103.0M | 96.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $163.8M | $125.0M |
| Short-term investments | $13.2M | $6.0M |
| Total debt | $43.1M | $6.6M |
| Total assets | $380.4M | $266.1M |
| Total liabilities | $117.1M | $71.1M |
| Shareholders' equity | $263.3M | $195.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology